Quality Review,Helicity was proved to play a crucial role on peptide specificity

The quest to understand and manipulate peptide structure, particularly the a-helical structure of peptides, is a cornerstone of modern biochemistry and drug discovery. A key focus in this field is the development of a model peptide with enhanced helicity. This pursuit is driven by the understanding that helicity was proved to play a crucial role on peptide specificity and biological activity. Researchers are continually exploring innovative strategies to achieve enhancement of this crucial secondary structure in peptides, leading to more stable, functional, and predictable molecular entities.

One significant approach involves the rational design of peptide sequences. For instance, studies have explored altering the sequence of a model monomeric peptide, such as acetylA(EAAAK)3Aamide, to facilitate easier measurement of peptide concentration and, crucially, to enhance its fractional helicity. This foundational work, like that by G. Merutka and colleagues, published in 1991, laid the groundwork for understanding how specific amino acid arrangements can influence helical content.

Further advancements have come from the concept of "stitched" or stapled peptides. These designs incorporate hydrocarbon staples that physically constrain the peptide backbone, thereby increasing its inherent tendency to form an a-helix. This strategy, explored by Verdine and coworkers, has shown remarkable success in not only enhancing helicity but also improving other desirable properties, such as protease stability and cellular uptake. The resulting stitched peptide displays enhanced bio-acceptability, including thermal and a-helical stability.

The role of specific amino acid residues in dictating peptide helicity is also a critical area of investigation. Research has demonstrated that short E-R/K peptides can exhibit significant helix content, with E-R interactions proving to be more influential in promoting helicity than similar E-K interactions. This highlights the subtle yet powerful impact of individual amino acid choices on the overall peptide structure. Moreover, modifications at specific positions, such as varying the ninth amino acid residue, which can act as a key anchoring residue, can significantly affect the helical structure of the peptide.

Beyond sequence modification, external factors and molecular interactions can also profoundly influence peptide helicity. For example, the presence of metal ions, such as silver ions (Ag+), has been shown to induce a strongly increased a-helicity in many peptides. This phenomenon suggests that metal-induced folding is a prevalent mechanism that can be leveraged in peptide design. Similarly, the environment surrounding a peptide, including the presence of model membranes, can significantly alter its helical conformation. Studies investigating Peptide helicity changes in the presence of model membranes reveal dynamic shifts in structure, which are critical for understanding peptide-membrane interactions, particularly for therapeutic agents like anticancer peptides (ACPs).

The broader implications of controlling peptide helicity extend to various biological functions. For a-helical antimicrobial peptides, helicity is directly correlated with their biological activities, including strong hemolytic activity. High hydrophobicity, amphipathicity, and high helicity are often observed together in potent antimicrobial agents. This understanding allows for the rational design of novel antimicrobial peptides with improved efficacy. The enhancement of a-helix mimicry is also a goal in developing a/b-peptide foldamers, which utilize dense arrays of acidic and basic side chains to preorganize a-helical structures.

In summary, the development of a model peptide with enhanced helicity is a multifaceted field encompassing sequence design, structural stabilization techniques like stapling, and an understanding of environmental influences. As research progresses, insights gained from studying peptide structure and function, often facilitated by computational tools and experimental techniques like circular dichroism (CD), continue to push the boundaries of what is possible in peptide engineering. The ongoing exploration into how to enhance the a-helical structure of peptides promises to yield next-generation therapeutics, biomaterials, and molecular tools.